UnitedHealth Group (UNH) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for June 2, 2025, with virtual attendance available for shareholders.
Shareholders of record as of April 4, 2025, are eligible to vote on key proposals.
Voting can be completed online, by phone, or by email, with confirmation available post-submission.
Voting matters and shareholder proposals
Election of ten directors is on the agenda, with board recommending a vote for all nominees.
Advisory vote on executive compensation is recommended for approval by the board.
Ratification of Deloitte & Touche LLP as independent auditor for 2025 is recommended for approval.
Shareholder proposal on excessive golden parachutes is opposed by the board.
Board of directors and corporate governance
Ten director nominees are listed, including individuals with diverse backgrounds and expertise.
Latest events from UnitedHealth Group
- Performance award goals and results for executives will be disclosed after 2026-2028.UNH
Proxy filing15 May 2026 - AI-driven growth, transparency, and operational efficiency are central to future performance.UNH
Bank of America Global Healthcare Conference 202613 May 2026 - Q1 2026 revenue up 2% to $111.7B, adjusted EPS $7.23, outlook raised above $18.25.UNH
Q1 20265 May 2026 - Board refreshment, AI investment, and executive pay changes highlight a focus on modernization and accountability.UNH
Proxy filing22 Apr 2026 - Board recommends all proposals except the independent Chair policy for the June 2026 meeting.UNH
Proxy filing22 Apr 2026 - AI-driven efficiencies and prudent growth strategies support strong 2024 outlook and future margins.UNH
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Q2 revenue up, net earnings down 23% amid cyberattack and South American losses.UNH
Q2 20243 Feb 2026 - 2026 guidance targets >$17.75 EPS, margin growth, and operational discipline amid funding headwinds.UNH
Q4 20252 Feb 2026 - Director elections, strategic growth, and cyberattack response highlighted; shareholder proposal failed.UNH
AGM 202431 Jan 2026 - Q3 2024 revenue up 9% to $100.8B; adjusted EPS $7.15, 2024 guidance steady despite disruptions.UNH
Q3 202419 Jan 2026